Active Not RecruitingNCT05174273
Official study titleUnderstanding the Neurocognitive Effects of Fecal Microbiota Transplantation in Major Depressive Disorder Patients With and Without Irritable Bowel Syndrome
This study is no longer accepting new participants.
In CalgaryDepressionInterventional studyAges 18–60
- Countries
- Canada
- Sponsor
- Valerie Taylor
SuspendedNCT06112652
Official study titleThe Dosage Effect of Personalized Brain Functional Sectors(pBFS) Guided rTMS Treatment for Treatment-resistance Depression: a Randomized, Double-Blind, Sham-controlled Trial
Recruitment is currently suspended.
In WuhanDepressionDevice studyAges 18–65
- Countries
- China
- Sponsor
- Changping Laboratory
CompletedNCT03096886
Official study titleNovel Neural Circuit Biomarkers of Major Depression Response to Computer-augmented CBT
This study has finished and is no longer accepting participants.
In PhiladelphiaDepressionBehavioural studyAges 18–60
- Countries
- United States
- Sponsor
- University of Pennsylvania
CompletedNCT05065580
Official study titleOsteopathic Manipulative Treatment as an Adjunctive Treatment in Major Depressive Disorder
This study has finished and is no longer accepting participants.
In Saint JosephDepressionInterventional studyAges 18–65
- Countries
- United States
- Sponsor
- Corewell Health South
Enrolling By InvitationNCT05935644
Official study titleORCHID: A Novel Positive Affect Intervention for Aging, Racial/Ethnic Minoritized Women With HIV (Miami)
This study is by invitation only.
In MiamiDepressionBehavioural studyAges 18–90
- Countries
- United States
- Sponsor
- University of Miami
CompletedNCT06391593
Official study titleDouble-Blind, Single and Multiple Dose Study to Determine Pharmacodynamic Markers, Pharmacokinetic Parameters, and Safety of ALTO-203 in Patients With Major Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including TucsonDepressionMedication studyAges 25–64
- Countries
- United States
- Sponsor
- Alto Neuroscience
CompletedNCT05712187
What is this study about?Researchers compared ALTO-100 and placebo to find out how the approaches affected depression symptoms in adults with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamDepressionMedication studyAges 18–64
- Countries
- United States
- Sponsor
- Alto Neuroscience
SuspendedNCT06705478
Official study titleAn Open-Label, Randomized Controlled Trial of Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
Recruitment is currently suspended.
Multiple locations, including BirminghamDepressionMedication studyAges 18–70
- Countries
- United States, Botswana, Brazil, + 11 others
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
TerminatedNCT06011577
Official study titleA Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as an Adjunctive Treatment for Major Depressive Disorder (RELIGHT)
This study ended early.
Multiple locations, including DothanDepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Levomecor Inc.
CompletedNCT04032301
Official study titleCharacterization of Comorbid Post-traumatic Stress Disorder and Major Depressive Disorder Utilizing Ketamine as an Experimental Medicine Probe
This study has finished and is no longer accepting participants.
In MinneapolisDepression, PTSDMedication studyAges 18–75
- Countries
- United States
- Sponsor
- University of Minnesota
TerminatedNCT01310140
Official study titleComparative Risks for Insulin Resistance and Metabolic Syndrome (MS) Among Hospitalized Patients With Major Depressive Disorder With (MDpsy) or Without (MDD) Psychotic Features
This study ended early.
In BostonDepression, SchizophreniaObservational studyAges 18–85
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT06126198
Official study title1 Hz RTMS Feasibility Study on Adolescent Treatment Resistant Major Depression
This study has finished and is no longer accepting participants.
In UppsalaDepression, BipolarityDevice studyAges 13–19
- Countries
- Sweden
- Sponsor
- Uppsala University